Mephedrone ban extended to entire EU

Europe has responded to rising concern over the use of the synthetic drug mephedrone by subjecting it to ‘control measures and criminal penalties’ throughout the EU. The EMCDDA Scientific Committee concluded that, while there is limited scientific evidence on its overall health and social risks, and that further studies are needed, mephedrone can cause acute health problems and potentially lead to dependency.

Links:

• Mephedrone ban across the EU. Drugnet Europe